|本期目录/Table of Contents|

曲妥珠单抗联合放疗对HER2高表达胃癌细胞的协同杀伤作用

《现代肿瘤医学》[ISSN:1672-4992/CN:61-1415/R]

期数:
2019年20期
页码:
3577-3579
栏目:
论着(基础研究)
出版日期:
2019-09-08

文章信息/Info

Title:
Synergism effect of trastuzumab combined with radiotherapy on HER2 overexpressed gastric cancer cell
作者:
韩真真;?鲁永织;?张龙杰;?宫 帅;?袁胜利
青岛市市立医院,山东 青岛 266011
Author(s):
Han Zhenzhen;?Lu Yongzhi;?Zhang Longjie;?Gong Shuai;?Yuan Shengli
Qingdao Municipal Hospital,Shandong Qingdao 266011,China.
关键词:
胃癌;?曲妥珠单抗;?HER2;?放射治疗
Keywords:
gastric cancer;?trastuzumab;?HER2;?radiotherapy
分类号:
R735.2
DOI:
10.3969/j.issn.1672-4992.2019.20.007
文献标识码:
A
qq自动领红包软件:
目的:研究曲妥珠单抗联合放疗对人类表皮生长因子受体2(HER2)高表达胃癌细胞NCI-N87的协同杀伤作用。方法:应用细胞增殖与毒性检测(CCK-8)法筛选曲妥珠单抗杀伤胃癌细胞的IC20浓度;将NCI-N87分为对照组与加药组,两组依次给予照射剂量不同的X线(0 Gy、2 Gy、4 Gy、6 Gy、8 Gy),应用克隆形成实验分析两者的杀伤作用;凋亡实验分4组:对照、曲妥珠单抗、2 Gy照射、2 Gy照射+曲妥珠单抗,流式细胞仪用于测定凋亡率。结果:IC20为10 μg/ml。与单纯放疗相比,曲妥珠单抗与放疗同时作用可明显降低细胞存活率,差异具有统计学意义(P<0.05)。凋亡率为对照(3.80±0.26)%、曲妥珠单抗(4.84±0.14)%、2 Gy照射(6.83±0.17)%、联合组(13.60±0.35)%,曲妥珠单抗或照射组均可增加NCI-N87细胞凋亡率,其中凋亡率在联合组中最高(P<0.05)。结论:曲妥珠单抗和放疗可协同杀伤HER2高表达的胃癌细胞。
Abstract:
Objective:To study the synergism effect of trastuzumab combined with radiotherapy on HER2 overexpressed gastric cancer cells.Methods:The inhibitory effect of trastuzumab on NCI-N87 cell proliferation was measured by CCK-8 assay in order to select the IC20 antibody concentration.NCI-N87 cells were divided into the control group and trastuzumab group.They were both treated with different doses of external irradiation (0 Gy,2 Gy,4 Gy,6 Gy,8 Gy).Then the clony formation assay was used to analyze the synergism effect.The experiment was divided into 4 groups:Control,trastuzumab,2 Gy irradiation and the combined group.Cell apoptosis was detected by the flow cytometry.Results:The IC20 of trastuzumab was 10 μg/ml.Compared with radiotherapy alone,trastuzumab combined with radiotherapy can significantly reduce cell viability (P<0.05).Apoptosis rates were in control (3.80±0.26)%,trastuzumab (4.84±0.14)%,2 Gy irradiation (6.83±0.17)% and the combined group (13.60±0.35)%.The cell apoptosis induction effect of the trastuzumab combined with radiotherapy group was better than the single treatment (P<0.05).Conclusion:Trastuzumab combined with radiotherapy has the synergism effect on HER2 overexpressed gastric cancer cells.

参考文献/References

[1] Davidson M,Okines AF,Starling N.Current and future therapies for advanced gastric cancer[J].Clin Colorectal Cancer,2015,14(4):239-250.
[2] Liu Y,Zhao G,Xu Y,et al.Phase II study of adjuvant chemoradiotherapy using docetaxel/cisplatin/5-fluorouracil before and after intensity-modulated radiotherapy with concurrent docetaxel in patients with completely (R0) resected gastric carcinoma[J].Am J Clin Oncol,2018,41(7):619-625.
[3] WANG Q,DONG HM,WANG WL,et al.Clinical efficacy observation of sequential chemoradiotherapy for locally advanced gastric cancer[J].Modern Oncology,2017,25(16):2605-2608.[王琴,董洪敏,王文玲,等.序贯化放疗治疗局部晚期胃癌的临床疗效[J].现代肿瘤医学,2017,25(16):2605-2608.]
[4] Min C,Bangalore S,Jhawar S,et al.Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection:A meta-analysis of randomized trials[J].Oncology,2014,86(2):79-85.
[5] Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386.
[6] FU T,JI JF.The foci and problems in diagnosis and treatment of gastric cancer[J].Chin J Clin Oncol,2016,43(1):2-5.[符涛,季加孚.胃癌诊疗的热点和问题[J].中国肿瘤临床,2016,43(1):2-5.]
[7] YAN ZY,MAI CY,GAO P,et al.Clinical significance of Her2 pathological expression in breast and gastric cancer patients[J].Chin J Immunol,2016,32(6):858-862.[闫振宇,买春阳,高鹏,等.Her2在乳腺癌和胃癌中表达的临床意义[J].中国免疫学杂志,2016,32(6):858-862.]
[8] WANG JH.Expression and significance of HER2 and β-catenin in esophageal carcinoma [J].Medical Science Journal of Central South China,2016,44(5):531-535.[王君化.HER2和β-catenin在食管癌中表达的临床病理意义[J].中南医学科学杂志,2016,44(5):531-535.]
[9] LU Y,JIANG BC,FEI JP.Expression of HER2/c-erbB-2 protein in gastric carcinoma and its clinical significance [J].Hainan Med J,2017,28(1):91-93.[陆艺,姜保成,费建平.HER2/c-erbB-2蛋白在胃癌组织中的表达及其临床意义[J].海南医学,2017,28(1):91-93.]
[10] Hou J,Zhou Z,Chen X,et al.HER2 reduces breast cancer radiosensitivity by activating focal adhesion kinase in vitro and in vivo [J].Oncotarget,2016,7(29):45186-45198.
[11] Van Cutsem E,Bang YJ,Feng-Yi F,et al.HER2 screening data from ToGA:Targeting HER2 in gastric and gastroesophageal junction cancer[J].Gastric Cancer,2015,18(3):476-484.
[12] Bang YJ,Van Cutsem E,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA):A phase 3,open-label,randomised controlled trial[J].Lancet,2010,376(9742):687-697.
[13] Liang K,Lu Y,Jin W,et al.Sensitization of breast cancer cells to radiation by trastuzumab[J].Mol Cancer Ther,2003,2(11):1113-1120.
[14] Uno M,Otsuki T,Kurebayashi J,et al.Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma [J].Int J Cancer,2001,94(4):474-479.
[15] Horton JK,Halle J,Ferraro M,et al.Radiosensitization of chemotherapy-refractory,locally advanced or locally recurrent breast cancer with trastuzumab:A phase II trial[J].Int J Radiat Oncol Biol Phys,2010,76(4):998-1004.
[16] HAN ZZ,YUAN SL,DING MC,et al.Observation of inhibitory effect of trastuzumab on HER-2 overexpressed gastric cancer line[J].Chin J Cancer Prevtreat,2013,8(20):593-595.[韩真真,袁胜利,丁明翠,等.曲妥珠单抗对HER-2高表达胃癌细胞珠抑制作用观察[J].中华肿瘤防治杂志,2013,8(20):593-595.]
[17] Kim SY,Kim HP,Kim YJ,et al.Trastuzumab inhibits the growth of human gastric cancer cell lines with HER2 amplification synergistically with cisplatin[J].Int J Oncol,2008,32(1):89-95.
[18] ZHOU YJ,XU XM.Research progress on factors influencing radiation sensitivity of hepatoma cells [J].Shandong Medical Journal,2017,53(23):105-108.[周宇杰,徐细明.肝癌细胞辐射敏感性影响因素的研究进展[J].山东医药,2017,53(23):105-108.]
[19] Fu Z,Chen D,Cheng H,et al.Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia[J].Med Sci Monit,2015(21):318-325.
[20] LUO B,YU SY,ZHANG L,et al.Effects of Herceptin on DNA-PKcs expression and activation in breast cancer cell line after X-irradiation exposure[J].Cancer Research On Prevention and Treatment,2009,36(6):462-465.[罗波,于世英,庄亮,等.Herceptin对X线照射后乳腺癌细胞DNA-PKcs表达和活性的影响[J].肿瘤防治研究,2009,36(6):462-465.]

备注/Memo

备注/Memo:
-
更新日期/Last Update: 1900-01-01